3-(4-(3-(5-fluoro-1H-indol-3-yl)propyl)piperazin-1-yl)benzo[d]isothiazole

ID: ALA4476294

PubChem CID: 141745657

Max Phase: Preclinical

Molecular Formula: C22H23FN4S

Molecular Weight: 394.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Fc1ccc2[nH]cc(CCCN3CCN(c4nsc5ccccc45)CC3)c2c1

Standard InChI:  InChI=1S/C22H23FN4S/c23-17-7-8-20-19(14-17)16(15-24-20)4-3-9-26-10-12-27(13-11-26)22-18-5-1-2-6-21(18)28-25-22/h1-2,5-8,14-15,24H,3-4,9-13H2

Standard InChI Key:  JEVQGJKCQNMIHY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   12.1285   -7.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1274   -8.5209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8354   -8.9299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8336   -7.2925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5422   -7.6978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5471   -8.5209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3314   -8.7708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8114   -8.1019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3236   -7.4389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4207   -7.2929    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.5716   -6.6602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3699   -6.4856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6179   -5.7069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4162   -5.5323    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9626   -6.1385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7578   -5.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0099   -5.1889    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4604   -4.5828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6587   -4.7544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8069   -5.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4154   -5.5631    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.1222   -5.1531    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.1377   -4.2704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9488   -4.3560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4265   -3.6973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0943   -2.9527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2798   -2.8708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8057   -3.5304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  1 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 20 21  2  0
 21 22  1  0
 22 24  1  0
 23 20  1  0
 17 20  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476294

    ---

Associated Targets(Human)

HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR7 Tclin Serotonin 7 (5-HT7) receptor (5576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Slc6a4 Serotonin transporter (6087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.52Molecular Weight (Monoisotopic): 394.1627AlogP: 4.67#Rotatable Bonds: 5
Polar Surface Area: 35.16Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.22CX LogP: 5.29CX LogD: 4.41
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -1.63

References

1. Gu ZS, Wang WT, Qian H, Zhou AN, Sun HB, Zhang QW, Li JQ..  (2019)  Synthesis and antidepressant effect of novel aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7.,  29  (23): [PMID:31627993] [10.1016/j.bmcl.2019.126703]

Source